| Financial Year |
March 31 2023 |
| Monetary Funds |
59,971,950.68 |
| Held-for-trading Financial Assets |
1,358,570,450.81 |
| Notes Receivable |
140,420,725.03 |
| Accounts Receivable |
264,123,013.91 |
| Advances to Suppliers |
48,993,031.95 |
| Other Receivables |
16,911,516.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
440,509,949.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
94,027,283.82 |
| Total Current Assets |
2,457,180,408.82 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
23,547,565.49 |
| Investment Properties |
221,675,240.80 |
| Fixed Assetes |
408,109,254.59 |
| Under-construction Projects |
80,908,971.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
203,253,658.67 |
| R&D expenses |
682,733.88 |
| Goodwill |
117,670,138.16 |
| Long-Term Deferred and Prepaid Expenses |
8,136,745.60 |
| Deferred Income Tax Assets |
16,007,672.14 |
| Other Non-Current Assets |
34,611,972.41 |
| Sub-Total of Non-Current Assets |
1,201,731,416.52 |
| Total Assets |
3,658,911,825.34 |
| Short-Term Loans |
650,426,332.03 |
| Trading Financial liabilities |
-- |
| Notes Payable |
177,746,486.60 |
| Accounts Payable |
96,302,793.69 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
22,914,980.03 |
| Taxes Payable |
13,018,554.91 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
38,686,515.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,354,727.17 |
| Other Current Liabilities |
51,217,603.07 |
| Sub-Total of Current Liabilities |
1,148,867,575.82 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
5,088,035.56 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,530,520.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
30,583,368.23 |
| Total Liabilities |
1,179,450,944.05 |
| Paid-In Capital(Or Share Stock) |
282,998,292.00 |
| Capital Surplus |
802,173,000.93 |
| Surplus Reserve |
122,941,690.75 |
| LESS:Treasury Stock |
5,620,396.89 |
| Undistributed Profits |
1,148,092,556.84 |
| Minority Stockholder's Interest |
128,841,590.25 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,350,619,291.04 |
| Owner's Equity（Stockholder's Equity） |
2,479,460,881.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,658,911,825.34 |
